MANHATTAN SCIENTIFICS INC Quarterly Nonoperating Income (Expense) in USD from Q3 2016 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Manhattan Scientifics Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2016 to Q4 2022.
  • Manhattan Scientifics Inc Nonoperating Income (Expense) for the quarter ending December 31, 2022 was -$222K, a 271% decline year-over-year.
  • Manhattan Scientifics Inc Nonoperating Income (Expense) for the twelve months ending December 31, 2022 was -$2.05M, a 30.5% increase year-over-year.
  • Manhattan Scientifics Inc annual Nonoperating Income (Expense) for 2022 was -$2.05M, a 30.5% increase from 2021.
  • Manhattan Scientifics Inc annual Nonoperating Income (Expense) for 2021 was -$2.95M, a 159% decline from 2020.
  • Manhattan Scientifics Inc annual Nonoperating Income (Expense) for 2020 was $4.99M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 -$2.05M -$222K -$352K -271% Oct 1, 2022 Dec 31, 2022 10-K 2023-04-13
Q3 2022 -$1.7M $97K +$1.08M Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$2.77M -$1.46M +$960K +39.6% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-15
Q1 2022 -$3.73M -$464K -$782K -246% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q4 2021 -$2.95M $130K -$2.8M -95.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-13
Q3 2021 -$149K -$978K -$2.94M -150% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $2.79M -$2.42M -$3.08M -469% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $5.87M $318K +$878K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $4.99M $2.93M +$3.89M Oct 1, 2020 Dec 31, 2020 10-K 2022-04-06
Q3 2020 $1.1M $1.96M +$563K +40.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $532K $656K +$1.07M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-23
Q1 2020 -$542K -$560K -$345K -160% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$197K -$961K Oct 1, 2019 Dec 31, 2019 10-K 2021-04-15
Q3 2019 $1.4M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$418K Apr 1, 2019 Jun 30, 2019 10-Q/A 2020-08-24
Q1 2019 -$215K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-20
Q3 2017 -$95K -$44K -86.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-19
Q3 2016 -$51K Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.